UG Healthcare Corporation Limited (SGX:8K7)
Singapore flag Singapore · Delayed Price · Currency is SGD
0.0770
+0.0010 (1.32%)
At close: Sep 9, 2026

UG Healthcare Corporation Financials Overview

Millions SGD. Fiscal year is Jul - Jun.

Revenue & Profits

Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Revenue
150.82150.82144.07115.21101.13232.6
Revenue Growth
3.24%4.69%25.06%13.91%-56.52%-31.27%
Gross Profit
42.8742.8734.7425.871.4584.39
Operating Income
5.565.56-0.82-6.63-25.1251.17
Net Income
2.12.1-4.1-3.96-20.7336.8
Earnings Per Share
0.000.00-0.01-0.01-0.030.06
EPS Growth
------69.45%

Revenue by Segment

Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Latex Examination Gloves
66.6766.67117.19119.01159.3233.56
Nitrile Examination Gloves
67.4467.44126.5387.7267.77241.62
Other Ancillary Products
16.7116.7126.5319.7911.6412.71
Inter-Segment
---126.18-111.32-137.57-255.29
Total
150.82150.82144.07115.21101.13232.6

Cash & Debt

Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Cash & Investments
27.4127.4123.292861.75100.22
Total Debt
40.5240.5247.3643.7231.1317.98
Net Cash (Debt)
-13.11-13.11-24.07-15.7230.6282.24
Net Cash Growth
-----62.77%59.07%
Net Cash Per Share
-0.02-0.02-0.04-0.030.050.13

Cash Flow & CapEx

Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Operating Cash Flow
16.9616.96-2.9-8.58-37.0153.95
Capital Expenditures
-2.62-2.62-3.16-2.51-7.69-20.74
Free Cash Flow
14.3514.35-6.05-11.1-44.733.21
Free Cash Flow Growth
161.58%-----47.44%

Margins

Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Gross Margin
28.42%28.42%24.11%22.45%1.43%36.28%
Operating Margin
3.68%3.68%-0.57%-5.75%-24.84%22.00%
Pretax Margin
2.65%2.65%-2.60%-6.07%-28.04%20.96%
Profit Margin
1.39%1.39%-2.84%-3.44%-20.50%15.82%
FCF Margin
9.51%9.51%-4.20%-9.63%-44.20%14.28%

Dividends

Fiscal YearFY 2022
Period EndingJun '22
Dividend Per Share
0.003
Dividend Per Share Growth
-21.18%
Dividend Yield
1.50%

Valuation

Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
PE Ratio
22.8922.89---3.73
Forward PE
-5.335.335.335.334.54
P/FCF Ratio
3.353.35---4.13
PS Ratio
0.320.320.470.650.890.59